Allergy Immunotherapies Market to grow by USD 1.01 billion from 2022 to 2027; Europe to account for 53% of market growth – Technavio

NEW YORK, Jan. 15, 2024 /PRNewswire/ — The allergy immunotherapies market is expected to grow by USD 1.01 billion from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of 8.95% during the forecast period, according to Technavio Research. The market has been…